New drug slows progression of type I diabetes

Teplizumab was approved late last year due to impressive results in slowing the progression of type 1 diabetes in children and adolescents. Now, the researchers present new data on the effectiveness of teplizumab, which can be used in the…

Diia users can get a year of free VPN

KeepSolid founders offer a free VPN Unlimited applet designed to protect user devices and bypass blocking. To get it, it is enough to pass verification. You can do this with the help of Actions. The initiative to provide free VPN access to…

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More